Cargando…
Glomerular proteomic profiling reveals early differences between preexisting and de novo type 2 diabetes in human renal allografts
BACKGROUND: Diabetes mellitus (DM), either preexisting or developing after transplantation, remains a crucial clinical problem in kidney transplantation. To obtain insights into the molecular mechanisms underlying PTDM development and early glomerular damage before the development of histologically...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10464146/ https://www.ncbi.nlm.nih.gov/pubmed/37626301 http://dx.doi.org/10.1186/s12882-023-03294-z |
_version_ | 1785098401006747648 |
---|---|
author | Kipp, Anne Marti, Hans-Peter Babickova, Janka Nakken, Sigrid Leh, Sabine Halden, Thea A. S. Jenssen, Trond Vikse, Bjørn Egil Åsberg, Anders Spagnoli, Giulio Furriol, Jessica |
author_facet | Kipp, Anne Marti, Hans-Peter Babickova, Janka Nakken, Sigrid Leh, Sabine Halden, Thea A. S. Jenssen, Trond Vikse, Bjørn Egil Åsberg, Anders Spagnoli, Giulio Furriol, Jessica |
author_sort | Kipp, Anne |
collection | PubMed |
description | BACKGROUND: Diabetes mellitus (DM), either preexisting or developing after transplantation, remains a crucial clinical problem in kidney transplantation. To obtain insights into the molecular mechanisms underlying PTDM development and early glomerular damage before the development of histologically visible diabetic kidney disease, we comparatively analysed the proteome of histologically normal glomeruli from patients with PTDM and normoglycaemic (NG) transplant recipients. Moreover, to assess specificities inherent in PTDM, we also comparatively evaluated glomerular proteomes from transplant recipients with preexisting type 2 DM (T2DM). METHODS: Protocol biopsies were obtained from adult NG, PTDM and T2DM patients one year after kidney transplantation. Biopsies were formalin-fixed and embedded in paraffin, and glomerular cross-sections were microdissected. A total of 4 NG, 7 PTDM and 6 T2DM kidney biopsies were used for the analysis. The proteome was determined by liquid chromatography-tandem mass spectrometry. Relative differences in protein abundance and significantly dysregulated pathways were analysed. RESULTS: Proteins involved in cell adhesion, immune response, leukocyte transendothelial filtration, and cell localization and organization were less abundant in glomeruli from PTDM patients than in those from NG patients, and proteins associated with supramolecular fibre organization and protein-containing complex binding were more abundant in PTDM patients. Overall, proteins related to adherens and tight junctions and those related to the immune system, including leukocyte transendothelial migration, were more abundant in NG patients than in transplanted patients with DM, irrespective of the timing of its development. However, proteins included in cell‒cell junctions and adhesion, insulin resistance, and vesicle-mediated transport were all less abundant in PTDM patients than in T2DM patients. CONCLUSIONS: The glomerular proteome profile differentiates PTDM from NG and T2DM, suggesting specific pathogenetic mechanisms. Further studies are warranted to validate these results, potentially leading to an improved understanding of PTDM kidney transplant pathophysiology and to the identification of novel biomarkers. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12882-023-03294-z. |
format | Online Article Text |
id | pubmed-10464146 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-104641462023-08-30 Glomerular proteomic profiling reveals early differences between preexisting and de novo type 2 diabetes in human renal allografts Kipp, Anne Marti, Hans-Peter Babickova, Janka Nakken, Sigrid Leh, Sabine Halden, Thea A. S. Jenssen, Trond Vikse, Bjørn Egil Åsberg, Anders Spagnoli, Giulio Furriol, Jessica BMC Nephrol Research Article BACKGROUND: Diabetes mellitus (DM), either preexisting or developing after transplantation, remains a crucial clinical problem in kidney transplantation. To obtain insights into the molecular mechanisms underlying PTDM development and early glomerular damage before the development of histologically visible diabetic kidney disease, we comparatively analysed the proteome of histologically normal glomeruli from patients with PTDM and normoglycaemic (NG) transplant recipients. Moreover, to assess specificities inherent in PTDM, we also comparatively evaluated glomerular proteomes from transplant recipients with preexisting type 2 DM (T2DM). METHODS: Protocol biopsies were obtained from adult NG, PTDM and T2DM patients one year after kidney transplantation. Biopsies were formalin-fixed and embedded in paraffin, and glomerular cross-sections were microdissected. A total of 4 NG, 7 PTDM and 6 T2DM kidney biopsies were used for the analysis. The proteome was determined by liquid chromatography-tandem mass spectrometry. Relative differences in protein abundance and significantly dysregulated pathways were analysed. RESULTS: Proteins involved in cell adhesion, immune response, leukocyte transendothelial filtration, and cell localization and organization were less abundant in glomeruli from PTDM patients than in those from NG patients, and proteins associated with supramolecular fibre organization and protein-containing complex binding were more abundant in PTDM patients. Overall, proteins related to adherens and tight junctions and those related to the immune system, including leukocyte transendothelial migration, were more abundant in NG patients than in transplanted patients with DM, irrespective of the timing of its development. However, proteins included in cell‒cell junctions and adhesion, insulin resistance, and vesicle-mediated transport were all less abundant in PTDM patients than in T2DM patients. CONCLUSIONS: The glomerular proteome profile differentiates PTDM from NG and T2DM, suggesting specific pathogenetic mechanisms. Further studies are warranted to validate these results, potentially leading to an improved understanding of PTDM kidney transplant pathophysiology and to the identification of novel biomarkers. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12882-023-03294-z. BioMed Central 2023-08-25 /pmc/articles/PMC10464146/ /pubmed/37626301 http://dx.doi.org/10.1186/s12882-023-03294-z Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Article Kipp, Anne Marti, Hans-Peter Babickova, Janka Nakken, Sigrid Leh, Sabine Halden, Thea A. S. Jenssen, Trond Vikse, Bjørn Egil Åsberg, Anders Spagnoli, Giulio Furriol, Jessica Glomerular proteomic profiling reveals early differences between preexisting and de novo type 2 diabetes in human renal allografts |
title | Glomerular proteomic profiling reveals early differences between preexisting and de novo type 2 diabetes in human renal allografts |
title_full | Glomerular proteomic profiling reveals early differences between preexisting and de novo type 2 diabetes in human renal allografts |
title_fullStr | Glomerular proteomic profiling reveals early differences between preexisting and de novo type 2 diabetes in human renal allografts |
title_full_unstemmed | Glomerular proteomic profiling reveals early differences between preexisting and de novo type 2 diabetes in human renal allografts |
title_short | Glomerular proteomic profiling reveals early differences between preexisting and de novo type 2 diabetes in human renal allografts |
title_sort | glomerular proteomic profiling reveals early differences between preexisting and de novo type 2 diabetes in human renal allografts |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10464146/ https://www.ncbi.nlm.nih.gov/pubmed/37626301 http://dx.doi.org/10.1186/s12882-023-03294-z |
work_keys_str_mv | AT kippanne glomerularproteomicprofilingrevealsearlydifferencesbetweenpreexistinganddenovotype2diabetesinhumanrenalallografts AT martihanspeter glomerularproteomicprofilingrevealsearlydifferencesbetweenpreexistinganddenovotype2diabetesinhumanrenalallografts AT babickovajanka glomerularproteomicprofilingrevealsearlydifferencesbetweenpreexistinganddenovotype2diabetesinhumanrenalallografts AT nakkensigrid glomerularproteomicprofilingrevealsearlydifferencesbetweenpreexistinganddenovotype2diabetesinhumanrenalallografts AT lehsabine glomerularproteomicprofilingrevealsearlydifferencesbetweenpreexistinganddenovotype2diabetesinhumanrenalallografts AT haldentheaas glomerularproteomicprofilingrevealsearlydifferencesbetweenpreexistinganddenovotype2diabetesinhumanrenalallografts AT jenssentrond glomerularproteomicprofilingrevealsearlydifferencesbetweenpreexistinganddenovotype2diabetesinhumanrenalallografts AT viksebjørnegil glomerularproteomicprofilingrevealsearlydifferencesbetweenpreexistinganddenovotype2diabetesinhumanrenalallografts AT asberganders glomerularproteomicprofilingrevealsearlydifferencesbetweenpreexistinganddenovotype2diabetesinhumanrenalallografts AT spagnoligiulio glomerularproteomicprofilingrevealsearlydifferencesbetweenpreexistinganddenovotype2diabetesinhumanrenalallografts AT furrioljessica glomerularproteomicprofilingrevealsearlydifferencesbetweenpreexistinganddenovotype2diabetesinhumanrenalallografts |